Pardes Bio

Pardes Biosciences was a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. Founded in 2020 and based in Carlsbad, California, it used structure-based drug design and a tunable, reversible covalent chemistry platform. Its lead candidate, PBI-0451, was an oral direct-acting antiviral for SARS-CoV-2. The company was acquired in 2023 and no longer operates independently. It has no public API, developer program, or technical integration surface, and its former domain (pardesbio.com) is now a parked/registrar page.

Pardes Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Biopharmaceutical, Pharmaceuticals, and Drug Discovery.

🌐 Visit website 📡 Source on GitHub
2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyBiopharmaceuticalPharmaceuticalsDrug DiscoveryAntiviralsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/pardes-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

apis.yml Raw ↑ 
aid: pardes-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/pardes-bio.png
name: Pardes Bio
description: Pardes Biosciences was a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing
  novel therapeutics to treat and prevent viral diseases. Founded in 2020 and based in Carlsbad, California, it used structure-based
  drug design and a tunable, reversible covalent chemistry platform. Its lead candidate, PBI-0451, was an oral direct-acting
  antiviral for SARS-CoV-2. The company was acquired in 2023 and no longer operates independently. It has no public API, developer
  program, or technical integration surface, and its former domain (pardesbio.com) is now a parked/registrar page.
url: https://raw.githubusercontent.com/api-evangelist/pardes-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
x-status: defunct
x-status-reason: acquired-2023; former domain pardesbio.com now parked; no API surface
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Biopharmaceutical
- Pharmaceuticals
- Drug Discovery
- Antivirals
- Life Sciences
apis: []
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io